Physiology and pathophysiology of the calcium-sensing receptor in the kidney

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 3, 2010, Pages

  Riccardi, Daniela ^a   Brown, Edward M ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Activating mutation; Autosomal dominant hypoparathyroidism; Calcimimetic; Collecting duct; Distal convoluted tubule; Familial hypocalciuric hypercalcemia; Hypercalcemia; Hypercalciuria; Hyperparathyroidism; Hypocalcemia; Inactivating mutation; Neonatal severe primary hyperparathyroidism; Parathyroid hormone; Polymorphism; Proximal tubule; Thick ascending limb

Indexed keywords

CALCILYTIC AGENT; CALCIUM ANTAGONIST; CALCIUM SENSING RECEPTOR; CINACALCET; PARATHYROID HORMONE; PHOSPHATE; UNCLASSIFIED DRUG; VITAMIN D;

ALLOSTERISM; AUTOSOMAL DOMINANT HYPOPARATHYROIDISM; BARTTER SYNDROME; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY; KIDNEY FAILURE; NONHUMAN; ONCOGENIC OSTEOMALACIA; PARATHYROID CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM;

EID: 77649147285     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00608.2009     Document Type: Review

References (172)

1. +-sensing receptor gene. J Clin Endocrinol Metab 80: 2594-2598, 1995.
2. Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol 3: 658-664, 2008.
3. + transport mechanisms in medullary thick ascending limb cells. Am J Physiol Cell Physiol 267: C1607-C1615, 1994.
4. Attie MF, Gill J Jr, Stock JL, Spiegel AM, Downs RW Jr, Levine MA, Marx SJ. Urinary calcium excretion in familial hypocalciuric hypercalcemia.Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 72: 667-676, 1983.
5. Auwerx J, Demedts M, Bouillon R. Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. Acta Endocrinologica (Copenh) 106: 215-218, 1984.
6. Awata H, Huang C, Handlogten ME, Miller RT. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276: 34871-34879, 2001.
7. Ba J, Brown D, Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 285: F1233-F1243, 2003.
8. 2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99: 88-96, 1997.
9. Barajas L. Anatomy of the juxtaglomerular apparatus. Am J Physiol Renal Fluid Electrolyte Physiol 237: F333-F343, 1979.
10. 2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 5: 601-606, 1996.
11. Beierwaltes WH. The role of calcium in the regulation of renin secretion. Am J Physiol Renal Physiol 298: F1-F11, 2010.
12. Blankenship KA, Williams JJ, Lawrence MS, McLeish KR, Dean WL, Arthur JM. The calcium-sensing receptor regulates calcium absorption in MDCK cells by inhibition of PMCA. Am J Physiol Renal Physiol 280: F815-F822, 2001.
13. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516-1525, 2004.
14. + channel.II.Cloning and distribution of alternative forms. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1132-F1140, 1995.
15. Bollerslev J, Wilson SG, Dick IM, Devine A, Dhaliwal SS, Prince RL. Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcif Tissue Int 74: 12-17, 2004.
16. Brauner-Osborne H, Wellendorph P, Jensen AA. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets 8: 169-184, 2007.
17. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism.In: Williams's Textbook of Endocrinology (9th ed.), edited by Wilson JD, Foster DW, Kronenberg HM, Larsen PR. Philadelphia: Saunders, 1998, p.1155-1209.
18. Brown EM. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin North Am 38: 437-445, 2009.
19. Brown EM. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab 3: 122-133, 2007.
20. 2+ and other ions as extracellular (first) messengers. Physiol Rev 71: 371-411, 1991.
21. 2+-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993.
22. Canaff L, Hendy GN. Human calcium-sensing receptor gene.Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277: 30337-30350, 2002.
23. Canaff L, Zhou X, Hendy GN. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem 283: 13586-13600, 2008.
24. Capasso G, Rizzo M, Pica A, Di Maio FS, Moe OW, Alpern RJ, De Santo NG. Bicarbonate reabsorption and NHE-3 expression: abundance and activity are increased in Henle's loop of remnant rats. Kidney Int 62: 2126-2135, 2002.
25. Carling T, Szabo E, Bai M, Ridefelt P, Westin G, Gustavsson P, Trivedi S, Hellman P, Brown EM, Dahl N, Rastad J. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85: 2042-2047, 2000.
26. Chang W, Tu C, Chen TH, Bikle D, Shoback D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1: ra1, 2008.
27. Charrie A, Chikh K, Peix JL, Berger N, Decaussin M, Veber S, Bienvenu J, Lifante JC, Fabien N. Calcium-sensing receptor autoantibodies in primary hyperparathyroidism. Clin Chim Acta 406: 94-97, 2009.
28. Chikatsu N, Fukumoto S, Suzawa M, Tanaka Y, Takeuchi Y, Takeda S, Tamura Y, Matsumoto T, Fujita T. An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor. Clin Endocrinol (Oxf) 50: 537-543, 1999.
29. Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) 69: 713-720, 2008.
30. Cole DE, Janicic N, Salisbury SR, Hendy GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium- sensing receptor gene. Am J Med Genet 71: 202-210, 1997.[Erratum. Am J Med Genet 72: October 17, 1997, p.251-252.]
31. Cole DE, Quamme GA. Inherited disorders of renal magnesium handling. J Am Soc Nephrol 11: 1937-1947, 2000.
32. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 83: 1083-1088, 1998.
33. 2+-sensing receptors. Biochem Soc Trans 35: 1195-1198, 2007.
34. Cooper L, Wertheimer J, Levey R, Brown E, Leboff M, Wilkinson R, Anast CS. Severe primary hyperparathyroidism in a neonate with two hypercalcemic parents: management with parathyroidectomy and heterotopic autotransplantation. Pediatrics 78: 263-268, 1986.
35. 2+ transport in cortical and medullary thick ascending limbs of mouse kidney. Pflügers Arch 417: 161-167, 1990.
36. Drueke TB, Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clin J Am Soc Nephrol 4: 234-241, 2009.
37. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, Riccardi D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 101: 5140-5145, 2004.
38. Eftekhari F, Yousefzadeh D. Primary infantile hyperparathyroidism: clinical, laboratory, and radiographic features in 21 cases. Skeletal Radiol 8: 201-208, 1982.
39. 3 in vivo independent of parathyroid hormone. Am J Physiol Renal Physiol 297: F720-F728, 2009.
40. el-Hajj Fuleihan G, Seifter J, Scott J, Brown EM. Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab 83: 2366-2372, 1998.
41. Epstein F. Calcium and the kidney. Am J Med 45: 700-713, 1968.
42. Esposito L, Rostaing L, Gennero I, Mehrenberger M, Durand D, Kamar N. Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient. Clin Nephrol 68: 245-248, 2007.
43. 2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett 436: 353-356, 1998.
44. + excretion in medullary thick ascending limbs of Henle's loop of mouse kidney. Tohoku J Exp Med 216: 7-15, 2008.
45. Fournier A, Shahapuni I, Harbouche L, Monge M. Calcimimetics for predialysis patients? Am J Kidney Dis 47: 196-107, 2006.
46. Fox L, Sadowsky J, Pringle KP, Kidd A, Murdoch J, Cole DE, Wiltshire E. Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant. Pediatrics 120: e1350-e1354, 2007.
47. Fray JC, Park CS, Valentine AN. Calcium and the control of renin secretion. Endocr Rev 8: 53-93, 1987.
48. Friedman PA. Calcium transport in the kidney. Curr Opin Nephrol Hypertens 8: 589-595, 1999.
49. Friedman PA, Coutermarsh BA, Kennedy SM, Gesek FA. Parathyroid hormone stimulation of calcium transport is mediated by dual signaling mechanisms involving protein kinase A and protein kinase C. Endocrinology 137: 13-20, 1996.
50. Garfia B, Canadillas S, Canalejo A, Luque F, Siendones E, Quesada M, Almaden Y, Aguilera-Tejero E, Rodriguez M. Regulation of parathyroid vitamin D receptor expression by extracellular calcium. J Am Soc Nephrol 13: 2945-2952, 2002.
51. Gattone VH 2nd, Chen NX, Sinders RM, Seifert MF, Duan D, Martin D, Henley C, Moe SM. Calcimimetic inhibits late-stage cyst growth in ADPKD. J Am Soc Nephrol 20: 1527-1532, 2009.
52. 2+-sensing receptor along the gastrointestinal tract. Annu Rev Physiol 71: 205-217, 2009.
53. Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT. Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 22: 931-937, 2007.
54. + exchanger NHE1 null mutant mice. Am J Physiol Renal Physiol 287: F1244-F1249, 2004.
55. Goodman WG, Quarles LD. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int 74: 276-288, 2008.
56. Gowen M, Stroup GB, Dodds RA, James IE, Votta BJ, Smith BR, Bhatnagar PK, Lago AM, Callahan JF, DelMar EG, Miller MA, Nemeth EF, Fox J. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 105: 1595-1604, 2000.
57. Harris SS, D'Ercole AJ. Neonatal hyperparathyroidism: the natural course in the absence of surgical intervention. Pediatrics 83: 53-56, 1989.
58. Hauache OM. Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Braz J Med Biol Res 34: 577-584, 2001.
59. Heath D. Familial benign hypercalcemia. Trends Endocrinol Metab 1: 6-9, 1989.
60. Heath DA. Clinical manifestations of abnormalities of the calcium sensing receptor. Clin Endocrinol (Oxf) 48: 257-8, 1998.
61. Heath DA. Familial hypocalciuric hypercalcemia.In: The Parathyroids, edited by Bilezikian JP, Marcus R, Levine MA.New York: Raven, 1994, p.699-710.
62. Heath H 3rd. Familial benign (hypocalciuric) hypercalcemia.A troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am 18: 723-740, 1989.
63. Heath H, 3rd, Jackson CE, Otterud B, Leppert MF. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53: 193-200, 1993.
64. Hebert SC. Molecular mechanisms. Semin Nephrol 19: 504-523, 1999.
65. 2+- sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200: 295-302, 1997.
66. Hebert SC, Riccardi D, Geibel J. The calcium-sensing receptor.In: The Kidney: Physiology and Pathophysiology (4th ed.), edited by Alpern RJ, Hebert SC.Amsterdam: Elsevier, 2007, p.1785-1882.
67. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16: 281-296, 2000.
68. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11: 389-394, 1995.
69. 2+ channels in health and disease. J Am Soc Nephrol 16: 15-26, 2005.
70. 2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice. Kidney Int 65: 531-539, 2004.
71. 2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metab 14: 282-288, 2003.
72. Huang C, Miller RT. The calcium-sensing receptor and its interacting proteins. J Cell Mol Med 11: 923-934, 2007.
73. Ikari A, Okude C, Sawada H, Sasaki Y, Yamazaki Y, Sugatani J, Degawa M, Miwa M. Activation of a polyvalent cation-sensing receptor decreases magnesium transport via claudin-16. Biochim Biophys Acta 1778: 283-290, 2008.
74. Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drueke TB, Massy ZA. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis 205: 55-62, 2009.
75. Jung J, Foroud TM, Eckert GJ, Flury-Wetherill L, Edenberg HJ, Xuei X, Zaidi SA, Pratt JH. Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans. J Clin Endocrinol Metab 94: 1042-1048, 2009.
76. Jung J, Sun B, Kwon D, Koller DL, Foroud TM. Allelic-based gene-gene interaction associated with quantitative traits. Genet Epidemiol 33: 332-343, 2009.
77. Kallay E, Wrba F, Cross HS. Dietary calcium and colon cancer prevention. Forum Nutr 56: 188-190, 2003.
78. Kantham L, Quinn SJ, Egbuna OI, Baxi K, Butters R, Pang JL, Pollak MR, Goltzman D, Brown EM. The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. Am J Physiol Endocrinol Metab 297: E915-E923, 2009.
79. Kemp EH, Gavilas NG, Krohn KJ, Brown EM, Watson PF, Weetman AP. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 94: 4749-4756, 2009.
80. Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath Hd. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 76: 715-720, 1993.
81. Kifor O, Diaz R, Butters R, Kifor I, Brown EM. The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 273: 21708-21713, 1998.
82. Kifor O, McElduff A, LeBoff MS, Moore FD Jr, Butters R, Gao P, Cantor TL, Kifor I, Brown EM. Activating antibodies to the calciumsensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 89: 548-556, 2004.
83. Kifor O, Moore FD Jr, Delaney M, Garber J, Hendy GN, Butters R, Gao P, Cantor TL, Kifor I, Brown EM, Wysolmerski J. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88: 60-72, 2003.
84. + transport in the kidney. Kidney Int Suppl 33: S95-S102, 1991.
85. Kobayashi M, Tanaka H, Tsuzuki K, Tsuyuki M, Igaki H, Ichinose Y, Aya K, Nishioka N, Seino Y. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 82: 2716-2719, 1997.
86. Kovacs CS, Ho-Pao CL, Hunzelman JL, Lanske B, Fox J, Seidman JG, Seidman CE, Kronenberg HM. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest 101: 2812-2820, 1998.
87. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 20: 1311-1314, 2005.
88. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971-977, 2000.
89. Law WM Jr, Bollman S, Kumar R, Heath IIIH. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism. J Clin Endocrinol Metab 58: 744-747, 1984.
90. Law WM Jr, Carney JA, Heath H III. Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia). Am J Med 76: 1021-1026, 1984.
91. Law WM Jr, Heath H III. Familial benign hypercalcemia (hypocalciuric hypercalcemia).Clinical and pathogenetic studies in 21 families. Ann Int Med 105: 511-519, 1985.
92. Levi R, Ben-Dov IZ, Lavi-Moshayoff V, Dinur M, Martin D, Naveh-Many T, Silver J. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol 17: 107-112, 2006.
93. Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabedian M. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 86: 5313-5323, 2001.
94. Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde JP, Boulesteix J, Rigaud M, Brown EM, Kottler ML. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 85: 1695-1702, 2000.
95. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 64: 189-195, 1999.
96. Maillard MP, Tedjani A, Perregaux C, Burnier M. Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat. J Hypertens 27: 1980-1987, 2009.
97. Maiti A, Beckman MJ. Extracellular calcium is a direct effecter of VDR levels in proximal tubule epithelial cells that counter-balances effects of PTH on renal vitamin D metabolism. J Steroid Biochem Mol Biol 103: 504-508, 2007.
98. Makita N, Sato J, Manaka K, Shoji Y, Oishi A, Hashimoto M, Fujita T, Iiri T. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci USA 104: 5443-5448, 2007.
99. Mamillapalli R, VanHouten J, Zawalich W, Wysolmerski J. Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem 283: 24435-24447, 2008.
100. Marx S, Lasker R, Brown E, Fitzpatrick L, Sweezey N, Goldbloom R, Gillis D, Cole D. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. J Clin Endocrinol Metab 62: 445-449, 1986.
101. Marx S, Spiegel A, Brown E, Koehler J, Gardner D, Brennan M, Aurbach G. Divalent cation metabolism.Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med 65: 235-242, 1978.
102. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60: 397-412, 1981.
103. Marx SJ, Attie MF, Stock JL, Spiegel AM, Levine MA. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 52: 736-740, 1981.
104. Marx SJ, Fraser D, Rapoport A. Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 78: 15-22, 1985.
105. Mathias R, Nguyen H, Zhang M, Portale A. Expression of the renal calcium-sensing receptor is reduced in rats with experimental chronic renal insufficiency (Abstract). J Bone Miner Res 12: S326, 1997.
106. Mentaverri R, Yano S, Chattopadhyay N, Petit L, Kifor O, Kamel S, Terwilliger EF, Brazier M, Brown EM. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 20: 2562-2564, 2006.
107. Motoyama HI, Friedman PA. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Renal Physiol 283: F399-F406, 2002.
108. Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E. Regulation of aquaporin-2 trafficking. Handb Exp Pharmacol: 133-157, 2009.
109. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434-1441, 2001.
110. 2+ in bovine parathyroid cells by external divalent cations. J Biol Chem 202: 5188-5196, 1987.
111. Nemeth EF, Fox J, Delmar EG, Steffey ME, Lambert LD, Conklin RL, Bhatnagar PK, Gowen M. Stimulation of parathyroid hormone secretion by a small molecule antagonist of the calcium receptor (Abstract). J Bone Miner Res 23: S156, 1998.
112. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95: 4040-4045, 1998.
113. Nielsen PK, Rasmussen AK, Butters R, Feldt-Rasmussen U, Bendtzen K, Diaz R, Brown EM, Olgaard K. Inhibition of PTH secretion by interleukin-1beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem Biophys Res Commun 238: 880-885, 1997.
114. Ortiz-Capisano MC, Liao TD, Ortiz PA, Beierwaltes WH. Calciumdependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells. Am J Physiol Regul Integr Comp Physiol 297: R1469-R1476, 2009.
115. Ortiz-Capisano MC, Ortiz PA, Garvin JL, Harding P, Beierwaltes WH. Expression and function of the calcium-sensing receptor in juxtaglomerular cells. Hypertension 50: 737-743, 2007.
116. Pallais JC, Kifor O, Chen YB, Slovik D, Brown EM. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calciumsensing receptor. N Engl J Med 351: 362-369, 2004.
117. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90: 135-141, 2005.
118. Pearce S, Coulthard M, Kendall-Taylor P, Thakker R. Autosomal dominant hypocalcemia associated with a mutation in the calciumsensing receptor (Abstract). J Bone Miner Res 10: S176, 1995.
119. Pearce SH. Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor. Ann Med 34: 201-206, 2002.
120. Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96: 2683-2692, 1995.
121. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115-1122, 1996.
122. Pearce SH, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV. Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 45: 675-680, 1996.
123. Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, Fontilla-Poole M, Mays RW, Brunden KR, Harrington JJ, Quarles LD. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 280: 40201-40209, 2005.
124. Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U, Hendy GN. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Hum Mol Genet 15: 2200-2209, 2006.
125. 2+-sensing receptor gene mutation. Nat Genet 8: 303-307, 1994.
126. Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.Effects of mutant gene dosage on phenotype. J Clin Invest 93: 1108-1112, 1994.
127. Procino G, Mastrofrancesco L, Mira A, Tamma G, Carmosino M, Emma F, Svelto M, Valenti G. Aquaporin 2 and apical calcium-sensing receptor: new players in polyuric disorders associated with hypercalciuria. Semin Nephrol 28: 297-305, 2008.
128. Quamme GA. Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60: 1275-1280, 1982.
129. Quamme GA, de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front Biosci 5: D694-D711, 2000.
130. - exchanger AE2 in rat thick ascending limb of Henle's loop in response to changes in acid-base and sodium balance. J Am Soc Nephrol 15: 2988-2997, 2004.
131. Quinn SJ, Bai M, Brown EM. pH sensing by the calcium-sensing receptor. J Biol Chem 279: 37241-37249, 2004.
132. Quinn SJ, Kifor O, Trivedi S, Diaz R, Vassilev P, Brown E.Sodium and ionic strength sensing by the calcium receptor. J Biol Chem 273: 19579-19586, 1998.
133. Renkema KY, Velic A, Dijkman HB, Verkaart S, van der Kemp AW, Nowik M, Timmermans K, Doucet A, Wagner CA, Bindels RJ, Hoen- derop JG. The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. J Am Soc Nephrol 20: 1705-1713, 2009.
134. Rhone DP. Primary neonatal hyperparathyroidism.Report of a case and review of the literature. Am J Clin Pathol 64: 488-499, 1975.
135. 2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol Renal Physiol 274: F611-F622, 1998.
136. 2+-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 271: F951-F956, 1996.
137. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, Hebert SC. Cloning and functional expression of a rat kidney extracellular calcium/ polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 92: 131-135, 1995.
138. i transporter (NaPi-2) in the rat proximal tubule. Pflügers Arch 441: 379-387, 2000.
139. Rivkees SA, El-Hajj Fuleihan G, Brown EM, Crawford JD. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 75: 1514-1518, 1992.
140. Rodriguez M, Aguilera-Tejero E, Mendoza FJ, Guerrero F, Lopez I. Effects of calcimimetics on extraskeletal calcifications in chronic kidney disease. Kidney Int Suppl: S50-S54, 2008.
141. Sands JM, Flores FX, Kato A, Baum MA, Brown EM, Ward DT, Hebert SC, Harris HW. Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats. Am J Physiol Renal Physiol 274: F978-F985, 1998.
142. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99: 1399-1405, 1997.
143. Scillitani A, Guarnieri V, DE Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN, Cole DE. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 89: 5634-5638, 2004.
144. 2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem 280: 37917-37923, 2005.
145. Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, Schwanauer LE, Olson KA, Klassen P, Bilezikian JP. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92: 3803-3808, 2007.
146. 2+ resorption. Science 285: 103-106, 1999.
147. Sloand JA, Shelly MA. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 48: 832-837, 2006.
148. Spiegel AM, Harrison HE, Marx SJ, Brown EM, Aurbach GD. Neonatal primary hyperparathyroidism with autosomal dominant inheritance. J Pediatr 90: 269-272, 1977.
149. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia. Evidence for humoral and non-humoral groups. N Engl J Med 303: 1377-1380, 1980.
150. Strewler GJ. Familial benign hypocalciuric hypercalcemia - from the clinic to the calcium sensor. West J Med 160: 579-580, 1994.
151. 2+ inhibits peptide hormone-dependent cAMP production specifically in thick ascending limbs of Henle. Miner Electr Metab 12: 342-346, 1986.
152. Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 42: 35-70, 2005.
153. Thogeirsson U, Costa J, Marx SJ. The parathyroid glands in familial hypocalciuric hypercalcemia. Hum Pathol 12: 229-237, 1981.
154. Timmers HJ, Karperien M, Hamdy NA, de Boer H, Hermus AR. Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. J Intern Med 260: 177-182, 2006.
155. 2+ channel TRPV5. Cell Calcium 45: 331-339, 2009.
156. Valenti G, Procino G, Tamma G, Carmosino M, Svelto M. Minireview: aquaporin 2 trafficking. Endocrinology 146: 5063-5070, 2005.
157. 2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest Liver Physiol 285: G78-G85, 2003.
158. VanHouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M, Wysolmerski JJ. The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 113: 598-608, 2004.
159. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13: 2259-2266, 2002.
160. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13: 2517-2523, 2002.
161. Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G, Soldati L. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 71: 1155-1162, 2007.
162. Waller S, Kurzawinski T, Spitz L, Thakker R, Cranston T, Pearce S, Cheetham T, van'T Hoff WG. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 163: 589-594, 2004.
163. + channels in rat TAL. Am J Physiol Renal Physiol 273: F421-F429, 1997.
164. + channels in the TAL. Am J Physiol Cell Physiol 271: C103-C111, 1996.
165. Ward DT, Riccardi D. Renal physiology of the extracellular calciumsensing receptor. Pflügers Arch 445: 169-176, 2002.
166. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360: 692-694, 2002.
167. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK, Schumacher MC, Lifton RP, Lalouel JM. Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension 18: I29 -I37, 1991.
168. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88: 4214-4220, 2003.
169. Yamamoto M, Akatsu T, Nagase T, Ogata E.Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders? J Clin Endocrinol Metab 85: 4583-4591, 2000.
170. Yano S, Sugimoto T, Kanzawa M, Tsukamoto T, Hattori T, Hattori S, Chihara K. Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 85: 317-323, 2000.
171. Yarden N, Lavelin I, Genina O, Hurwitz S, Diaz R, Brown EM, Pines M. Expression of calcium-sensing receptor gene by avian parathyroid gland in vivo: relationship to plasma calcium. Gen Comp Endocrinol 117: 173-181, 2000.
172. Yokoyama K, Shigematsu T, Tsukada T, Hara S, Yamada A, Kawaguchi Y, Hosoya T. Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease. Clin Nephrol 57: 131-135, 2002.